Understanding regulatory pathways of neovascularization in diabetes

References

• Mcgrath JC, Deighan C, Briones AM, et al. New aspects of vascular remodelling: the involvement of all vascular cell types. Exp Physiol 2005;90(4):469-75
   Google Scholar
• Li J, Zhang YP, Kirsner RS. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc Res Tech 2003;60(1):107-14
   PubMed Web of Science ®Google Scholar
• Crisan M, Yap S, Casteilla L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3(3):301-13
   PubMed Web of Science ®Google Scholar
• Ranganath SH, Levy O, Inamdar MS, Karp JM. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 2012;10(3):244-58
   PubMed Web of Science ®Google Scholar
• Hung SC, Pochampally RR, Chen SC, et al. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 2007;25(9):2363-70
   PubMed Web of Science ®Google Scholar
• Aicher A, Brenner W, Zuhayra M, et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003;107(16):2134-9
   PubMed Web of Science ®Google Scholar
• Smart N, Riley PR. The stem cell movement. Circ Res 2008;102(10):1155-68
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011;473(7347):298-307
   PubMed Web of Science ®Google Scholar
• Risau W, Sariola H, Zerwes HG, et al. Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 1988;102(3):471-8
   Google Scholar
• Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995;11:73-91
   PubMed Web of Science ®Google Scholar
• Tepper OM, Capla JM, Galiano RD, et al. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005;105(3):1068-77
   PubMed Web of Science ®Google Scholar
• Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275(5302):964-7
   PubMed Web of Science ®Google Scholar
• Heil M, Schaper W. Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ Res 2004;95(5):449-58
   Google Scholar
• Fortes ZB, Garcia Leme J, Scivoletto R. Influence of diabetes on the reactivity of mesenteric microvessels to histamine, bradykinin and acetylcholine. Br J Pharmacol 1983;78(1):39-48
   Google Scholar
• Hammes HP, Martin S, Federlin K, et al. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 1991;88(24):11555-8
   Google Scholar
• Rosso A, Balsamo A, Gambino R, et al. p53 Mediates the accelerated onset of senescence of endothelial progenitor cells in diabetes. J Biol Chem 2006;281(7):4339-47
   Google Scholar
• He Z, Opland DM, Way KJ, et al. Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia. Arterioscler Thromb Vasc Biol 2006;26(4):787-93
   Google Scholar
• Goova MT, Li J, Kislinger T, et al. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 2001;159(2):513-25
   Google Scholar
• Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007;127(3):514-25
   PubMed Web of Science ®Google Scholar
• Mahdavian Delavary B, Van Der Veer WM, Van Egmond M, et al. Macrophages in skin injury and repair. Immunobiology 2011;216(7):753-62
   PubMed Web of Science ®Google Scholar
• Botusan IR, Sunkari VG, Savu O, et al. Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci USA 2008;105(49):19426-31
   PubMed Web of Science ®Google Scholar
• Schatteman GC, Hanlon HD, Jiao C, et al. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000;106(4):571-8
   Google Scholar
• Sarkar K, Fox-Talbot K, Steenbergen C, et al. Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proc Natl Acad Sci USA 2009;106(44):18769-74
   PubMed Web of Science ®Google Scholar
• Koyama N, Watanabe S, Tezuka M, et al. Migratory and proliferative effect of platelet-derived growth factor in rabbit retinal endothelial cells: evidence of an autocrine pathway of platelet-derived growth factor. J Cell Physiol 1994;158(1):1-6
   Google Scholar
• Costa C, Incio J, Soares R. Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 2007;10(3):149-66
   PubMedGoogle Scholar
• Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 2010;106(8):1319-31
   PubMed Web of Science ®Google Scholar
• Devi MS, Sudhakaran PR. Differential modulation of angiogenesis by advanced glycation end products. Exp Biol Med (Maywood) 2011;236(1):52-61
   Google Scholar
• Wilkinson-Berka JL, Tan G, Jaworski K, Miller AG. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology. Circ Res 2009;104(1):124-33
   PubMed Web of Science ®Google Scholar
• Howangyin KY, Silvestre JS. Diabetes mellitus and ischemic diseases: molecular mechanisms of vascular repair dysfunction. Arterioscler Thromb Vasc Biol 2014;34(6):1126-35
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 1998;8(5):588-94
   PubMed Web of Science ®Google Scholar
• Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995;92(12):5510-14
   PubMed Web of Science ®Google Scholar
• Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001;292(5516):468-72
   PubMed Web of Science ®Google Scholar
• Ivan M, Kondo K, Yang H, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001;292(5516):464-8
   PubMed Web of Science ®Google Scholar
• Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006;70(5):1469-80
   PubMed Web of Science ®Google Scholar
• Kimura H, Weisz A, Ogura T, et al. Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem 2001;276(3):2292-8
   PubMed Web of Science ®Google Scholar
• Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10(8):858-64
   PubMed Web of Science ®Google Scholar
• Connolly DT. Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem 1991;47(3):219-23
   Google Scholar
• Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007;19(10):2003-12
   PubMed Web of Science ®Google Scholar
• Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling – in control of vascular function. Nat Rev Mol Cell Biol 2006;7(5):359-71
   PubMed Web of Science ®Google Scholar
• Kucia M, Reca R, Miekus K, et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005;23(7):879-94
   PubMed Web of Science ®Google Scholar
• Mace KA, Yu DH, Paydar KZ, et al. Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair. Wound Repair Regen 2007;15(5):636-45
   PubMed Web of Science ®Google Scholar
• Marfella R, D’amico M, Di Filippo C, et al. Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 2002;45(8):1172-81
   PubMed Web of Science ®Google Scholar
• Gao W, Ferguson G, Connell P, et al. High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth via a HIF-1alpha-dependent pathway. J Mol Cell Cardiol 2007;42(3):609-19
   Google Scholar
• Catrina SB, Okamoto K, Pereira T, et al. Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. Diabetes 2004;53(12):3226-32
   PubMed Web of Science ®Google Scholar
• Yamada N, Horikawa Y, Oda N, et al. Genetic variation in the hypoxia-inducible factor-1alpha gene is associated with type 2 diabetes in Japanese. J Clin Endocrinol Metab 2005;90(10):5841-7
   PubMed Web of Science ®Google Scholar
• Resar JR, Roguin A, Voner J, et al. Hypoxia-inducible factor 1alpha polymorphism and coronary collaterals in patients with ischemic heart disease. Chest 2005;128(2):787-91
   Google Scholar
• Bento CF, Fernandes R, Ramalho J, et al. The chaperone-dependent ubiquitin ligase CHIP targets HIF-1alpha for degradation in the presence of methylglyoxal. PLoS One 2010;5(11):e15062
   Google Scholar
• Yang P, Reece EA. Role of HIF-1alpha in maternal hyperglycemia-induced embryonic vasculopathy. Am J Obstet Gynecol 2011;204(4):332 e331-7
   Google Scholar
• Yu DH, Mace KA, Hansen SL, et al. Effects of decreased insulin-like growth factor-1 stimulation on hypoxia inducible factor 1-alpha protein synthesis and function during cutaneous repair in diabetic mice. Wound Repair Regen 2007;15(5):628-35
   Google Scholar
• Chen JX, Stinnett A. Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice. Diabetes 2008;57(12):3335-43
   Google Scholar
• Rivard A, Silver M, Chen D, et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999;154(2):355-63
   PubMed Web of Science ®Google Scholar
• Ceradini DJ, Yao D, Grogan RH, et al. Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J Biol Chem 2008;283(16):10930-8
   Google Scholar
• Thangarajah H, Yao D, Chang EI, et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci USA 2009;106(32):13505-10
   PubMed Web of Science ®Google Scholar
• Frank S, Hubner G, Breier G, et al. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995;270(21):12607-13
   PubMed Web of Science ®Google Scholar
• Zykova SN, Jenssen TG, Berdal M, et al. Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 2000;49(9):1451-8
   Google Scholar
• Altavilla D, Saitta A, Cucinotta D, et al. Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes 2001;50(3):667-74
   Google Scholar
• Ozawa K, Kondo T, Hori O, et al. Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport. J Clin Invest 2001;108(1):41-50
   PubMed Web of Science ®Google Scholar
• Romano Di Peppe S, Mangoni A, Zambruno G, et al. Adenovirus-mediated VEGF(165) gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice. Gene Ther 2002;9(19):1271-7
   Google Scholar
• Restivo TE, Mace KA, Harken AH, Young DM. Application of the chemokine CXCL12 expression plasmid restores wound healing to near normal in a diabetic mouse model. J Trauma 2010;69(2):392-8
   Google Scholar
• Gallagher KA, Liu ZJ, Xiao M, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007;117(5):1249-59
   PubMed Web of Science ®Google Scholar
• Chen J, Chen J, Chen S, et al. Transfusion of CXCR4-primed endothelial progenitor cells reduces cerebral ischemic damage and promotes repair in db/db diabetic mice. PLoS One 2012;7(11):e50105
   Google Scholar
• Kajiwara H, Luo Z, Belanger AJ, et al. A hypoxic inducible factor-1 alpha hybrid enhances collateral development and reduces vascular leakage in diabetic rats. J Gene Med 2009;11(5):390-400
   Google Scholar
• Ko SH, Nauta A, Morrison SD, et al. Antimycotic ciclopirox olamine in the diabetic environment promotes angiogenesis and enhances wound healing. PLoS One 2011;6(11):e27844
   PubMed Web of Science ®Google Scholar
• Wetterau M, George F, Weinstein A, et al. Topical prolyl hydroxylase domain-2 silencing improves diabetic murine wound closure. Wound Repair Regen 2011;19(4):481-6
   PubMed Web of Science ®Google Scholar
• Howangyin KY, Loinard C, Bakker W, et al. HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia. Stem Cells 2014;32(1):231-43
   PubMed Web of Science ®Google Scholar
• Huang M, Chan DA, Jia F, et al. Short hairpin RNA interference therapy for ischemic heart disease. Circulation 2008;118(14 Suppl):S226-33
   PubMed Web of Science ®Google Scholar
• Lijkwan MA, Hellingman AA, Bos EJ, et al. Short hairpin RNA gene silencing of prolyl hydroxylase-2 with a minicircle vector improves neovascularization of hindlimb ischemia. Hum Gene Ther 2014;25(1):41-9
   PubMed Web of Science ®Google Scholar
• Thangarajah H, Vial IN, Grogan RH, et al. HIF-1alpha dysfunction in diabetes. Cell Cycle 2010;9(1):75-9
   PubMed Web of Science ®Google Scholar
• Fiorina P, Pietramaggiori G, Scherer SS, et al. The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing. Cell Transplant 2010;19(11):1369-81
   PubMed Web of Science ®Google Scholar
• Thiersch M, Rimann M, Panagiotopoulou V, et al. The angiogenic response to PLL-g-PEG-mediated HIF-1alpha plasmid DNA delivery in healthy and diabetic rats. Biomaterials 2013;34(16):4173-82
   PubMed Web of Science ®Google Scholar
• Badillo AT, Chung S, Zhang L, et al. Lentiviral gene transfer of SDF-1alpha to wounds improves diabetic wound healing. J Surg Res 2007;143(1):35-42
   PubMed Web of Science ®Google Scholar
• Di Rocco G, Gentile A, Antonini A, et al. Enhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromal-derived factor-1: biodistribution and engraftment analysis by bioluminescent imaging. Stem Cells Int 2010;2011:304562
   PubMed Web of Science ®Google Scholar
• Liu ZJ, Tian R, An W, et al. Identification of E-selectin as a novel target for the regulation of postnatal neovascularization: implications for diabetic wound healing. Ann Surg 2010;252(4):625-34
   PubMed Web of Science ®Google Scholar
• Gao W, Qiao X, Ma S, Cui L. Adipose-derived stem cells accelerate neovascularization in ischaemic diabetic skin flap via expression of hypoxia-inducible factor-1alpha. J Cell Mol Med 2011;15(12):2575-85
   Google Scholar
• Castilla DM, Liu ZJ, Tian R, et al. A novel autologous cell-based therapy to promote diabetic wound healing. Ann Surg 2012;256(4):560-72
   PubMed Web of Science ®Google Scholar
• Dong L, Kang L, Ding L, et al. Insulin modulates ischemia-induced endothelial progenitor cell mobilization and neovascularization in diabetic mice. Microvasc Res 2011;82(3):227-36
   Google Scholar
• Meng D, Mei A, Liu J, et al. NADPH oxidase 4 mediates insulin-stimulated HIF-1alpha and VEGF expression, and angiogenesis in vitro. PLoS One 2012;7(10):e48393
   Google Scholar
• Lima MH, Caricilli AM, De Abreu LL, et al. Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: a double-blind placebo-controlled clinical trial. PLoS One 2012;7(5):e36974
   PubMed Web of Science ®Google Scholar
• Nishimura Y, Ii M, Qin G, et al. CXCR4 antagonist AMD3100 accelerates impaired wound healing in diabetic mice. J Invest Dermatol 2012;132(3 Pt 1):711-20
   Google Scholar
• Nguyen PD, Tutela JP, Thanik VD, et al. Improved diabetic wound healing through topical silencing of p53 is associated with augmented vasculogenic mediators. Wound Repair Regen 2010;18(6):553-9
   PubMed Web of Science ®Google Scholar
• Bala K, Gohil NK. Interaction of glycated protein and DFO mimicked hypoxia in cellular responses of HUVECs. Mol Biosyst 2012;8(10):2657-63
   Google Scholar
• Lin M, Chen Y, Jin J, et al. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Muller cells. Diabetologia 2011;54(6):1554-66
   Google Scholar
• Ristoiu V, Shibasaki K, Uchida K, et al. Hypoxia-induced sensitization of transient receptor potential vanilloid 1 involves activation of hypoxia-inducible factor-1 alpha and PKC. Pain 2011;152(4):936-45
   Google Scholar
• Pe’er J, Shweiki D, Itin A, et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 1995;72(6):638-45
   PubMed Web of Science ®Google Scholar
• Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994;118(4):445-50
   PubMed Web of Science ®Google Scholar
• Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331(22):1480-7
   PubMed Web of Science ®Google Scholar
• Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995;92(23):10457-61
   PubMed Web of Science ®Google Scholar
• Haurigot V, Villacampa P, Ribera A, et al. Long-term retinal PEDF overexpression prevents neovascularization in a murine adult model of retinopathy. PLoS One 2012;7(7):e41511
   PubMed Web of Science ®Google Scholar
• Chen LY, Zhuo YH, Li YH, et al. Expression of stromal cell-derived factor-1 in diabetic retinopathy. Chin Med J (Engl) 2010;123(8):984-8
   Google Scholar
• Butler JM, Guthrie SM, Koc M, et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest 2005;115(1):86-93
   Google Scholar
• Cross MJ, Claesson-Welsh L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 2001;22(4):201-7
   Google Scholar
• Dor Y, Keshet E. Ischemia-driven angiogenesis. Trends Cardiovasc Med 1997;7(8):289-94
   PubMed Web of Science ®Google Scholar
• Boulton M, Gregor Z, Mcleod D, et al. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management. Br J Ophthalmol 1997;81(3):228-33
   Google Scholar
• Ozaki H, Okamoto N, Ortega S, et al. Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. Am J Pathol 1998;153(3):757-65
   Google Scholar
• Simo R, Carrasco E, Garcia-Ramirez M, Hernandez C. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev 2006;2(1):71-98
   PubMedGoogle Scholar
• Peplow PV, Baxter GD. Gene expression and release of growth factors during delayed wound healing: a review of studies in diabetic animals and possible combined laser phototherapy and growth factor treatment to enhance healing. Photomed Laser Surg 2012;30(11):617-36
   Google Scholar
• Duraisamy Y, Slevin M, Smith N, et al. Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: possible relevance to wound healing in diabetes. Angiogenesis 2001;4(4):277-88
   Google Scholar
• Callaghan MJ, Chang EI, Seiser N, et al. Pulsed electromagnetic fields accelerate normal and diabetic wound healing by increasing endogenous FGF-2 release. Plast Reconstr Surg 2008;121(1):130-41
   PubMed Web of Science ®Google Scholar
• Obara K, Ishihara M, Fujita M, et al. Acceleration of wound healing in healing-impaired db/db mice with a photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2. Wound Repair Regen 2005;13(4):390-7
   Google Scholar
• Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999;79(4):1283-316
   PubMed Web of Science ®Google Scholar
• Freyberger H, Brocker M, Yakut H, et al. Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy. Exp Clin Endocrinol Diabetes 2000;108(2):106-9
   PubMed Web of Science ®Google Scholar
• Doxey DL, Ng MC, Dill RE, Iacopino AM. Platelet-derived growth factor levels in wounds of diabetic rats. Life Sci 1995;57(11):1111-23
   Google Scholar
• Ikuno Y, Kazlauskas A. An in vivo gene therapy approach for experimental proliferative vitreoretinopathy using the truncated platelet-derived growth factor alpha receptor. Invest Ophthalmol Vis Sci 2002;43(7):2406-11
   Google Scholar
• Greenhalgh DG, Sprugel KH, Murray MJ, Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990;136(6):1235-46
   PubMed Web of Science ®Google Scholar
• Lee JA, Conejero JA, Mason JM, et al. Lentiviral transfection with the PDGF-B gene improves diabetic wound healing. Plast Reconstr Surg 2005;116(2):532-8
   PubMed Web of Science ®Google Scholar
• Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998;67:753-91
   PubMed Web of Science ®Google Scholar
• Sato Y, Rifkin DB. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol 1989;109(1):309-15
   Web of Science ®Google Scholar
• Baldysiak-Figiel A, Lang GK, Kampmeier J, Lang GE. Octreotide prevents growth factor-induced proliferation of bovine retinal endothelial cells under hypoxia. J Endocrinol 2004;180(3):417-24
   Google Scholar
• Hirase K, Ikeda T, Sotozono C, et al. Transforming growth factor beta2 in the vitreous in proliferative diabetic retinopathy. Arch Ophthalmol 1998;116(6):738-41
   Google Scholar
• Spranger J, Meyer-Schwickerath R, Klein M, et al. Deficient activation and different expression of transforming growth factor-beta isoforms in active proliferative diabetic retinopathy and neovascular eye disease. Exp Clin Endocrinol Diabetes 1999;107(1):21-8
   Google Scholar
• Vogt PM, Lehnhardt M, Wagner D, et al. Determination of endogenous growth factors in human wound fluid: temporal presence and profiles of secretion. Plast Reconstr Surg 1998;102(1):117-23
   Google Scholar
• Grainger DJ, Wakefield L, Bethell HW, et al. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med 1995;1(9):932-7
   Google Scholar
• Bitar MS, Labbad ZN. Transforming growth factor-beta and insulin-like growth factor-I in relation to diabetes-induced impairment of wound healing. J Surg Res 1996;61(1):113-19
   Google Scholar
• Al-Mulla F, Leibovich SJ, Francis IM, Bitar MS. Impaired TGF-beta signaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetes. Mol Biosyst 2011;7(11):3006-20
   PubMedGoogle Scholar
• Badr G, Badr BM, Mahmoud MH, et al. Treatment of diabetic mice with undenatured whey protein accelerates the wound healing process by enhancing the expression of MIP-1alpha, MIP-2, KC, CX3CL1 and TGF-beta in wounded tissue. BMC Immunol 2012;13:32
   PubMed Web of Science ®Google Scholar
• Nusse R. Cell biology: relays at the membrane. Nature 2005;438(7069):747-9
   Google Scholar
• Nusse R, Varmus HE. Wnt genes. Cell 1992;69(7):1073-87
   PubMed Web of Science ®Google Scholar
• Tamai K, Semenov M, Kato Y, et al. LDL-receptor-related proteins in Wnt signal transduction. Nature 2000;407(6803):530-5
   PubMed Web of Science ®Google Scholar
• Nusse R. Wnt signaling in disease and in development. Cell Res 2005;15(1):28-32
   PubMed Web of Science ®Google Scholar
• Wang H, Charles PC, Wu Y, et al. Gene expression profile signatures indicate a role for Wnt signaling in endothelial commitment from embryonic stem cells. Circ Res 2006;98(10):1331-9
   PubMedGoogle Scholar
• Dufourcq P, Couffinhal T, Ezan J, et al. FrzA, a secreted frizzled related protein, induced angiogenic response. Circulation 2002;106(24):3097-103
   Google Scholar
• Ezan J, Leroux L, Barandon L, et al. FrzA/sFRP-1, a secreted antagonist of the Wnt-Frizzled pathway, controls vascular cell proliferation in vitro and in vivo. Cardiovasc Res 2004;63(4):731-8
   PubMed Web of Science ®Google Scholar
• Masckauchan TN, Kitajewski J. Wnt/Frizzled signaling in the vasculature: new angiogenic factors in sight. Physiology (Bethesda) 2006;21:181-8
   PubMed Web of Science ®Google Scholar
• Samarzija I, Sini P, Schlange T, et al. Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways. Biochem Biophys Res Commun 2009;386(3):449-54
   Google Scholar
• Barcelos LS, Duplaa C, Krankel N, et al. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res 2009;104(9):1095-102
   Google Scholar
• Chen Y, Hu Y, Zhou T, et al. Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. Am J Pathol 2009;175(6):2676-85
   Google Scholar
• Zhang B, Abreu JG, Zhou K, et al. Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family. Proc Natl Acad Sci USA 2010;107(15):6900-5
   Google Scholar
• Zhou T, Zhou KK, Lee K, et al. The role of lipid peroxidation products and oxidative stress in activation of the canonical wingless-type MMTV integration site (WNT) pathway in a rat model of diabetic retinopathy. Diabetologia 2011;54(2):459-68
   PubMed Web of Science ®Google Scholar
• Lee K, Hu Y, Ding L, et al. Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy. Diabetes 2012;61(11):2948-57
   PubMed Web of Science ®Google Scholar
• Caporali A, Emanueli C. Cardiovascular actions of neurotrophins. Physiol Rev 2009;89(1):279-308
   PubMed Web of Science ®Google Scholar
• Caporali A, Meloni M, Miller AM, et al. Soluble ST2 is regulated by p75 neurotrophin receptor and predicts mortality in diabetic patients with critical limb ischemia. Arterioscler Thromb Vasc Biol 2012;32(12):e149-60
   PubMed Web of Science ®Google Scholar
• Caporali A, Pani E, Horrevoets AJ, et al. Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles. Circ Res 2008;103(2):e15-26
   PubMed Web of Science ®Google Scholar
• Johnson D, Lanahan A, Buck CR, et al. Expression and structure of the human NGF receptor. Cell 1986;47(4):545-54
   PubMed Web of Science ®Google Scholar
• Kim H, Li Q, Hempstead BL, Madri JA. Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells. J Biol Chem 2004;279(32):33538-46
   PubMed Web of Science ®Google Scholar
• Kraemer R. Reduced apoptosis and increased lesion development in the flow-restricted carotid artery of p75(NTR)-null mutant mice. Circ Res 2002;91(6):494-500
   Google Scholar
• Tamarat R, Silvestre JS, Huijberts M, et al. Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice. Proc Natl Acad Sci USA 2003;100(14):8555-60
   Google Scholar
• Shoji T, Koyama H, Morioka T, et al. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes 2006;55(8):2245-55
   Google Scholar
• Liu H, Yu S, Zhang H, Xu J. Angiogenesis impairment in diabetes: role of methylglyoxal-induced receptor for advanced glycation endproducts, autophagy and vascular endothelial growth factor receptor 2. PLoS One 2012;7(10):e46720
   Google Scholar
• Fadini GP, Miorin M, Facco M, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005;45(9):1449-57
   PubMed Web of Science ®Google Scholar
• Fadini GP, Sartore S, Schiavon M, et al. Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia 2006;49(12):3075-84
   Google Scholar
• Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348(7):593-600
   PubMed Web of Science ®Google Scholar
• Caballero S, Sengupta N, Afzal A, et al. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes 2007;56(4):960-7
   PubMed Web of Science ®Google Scholar
• Tamarat R, Silvestre JS, Le Ricousse-Roussanne S, et al. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am J Pathol 2004;164(2):457-66
   Google Scholar
• Yuen DA, Zhang Y, Thai K, et al. Angiogenic dysfunction in bone marrow-derived early outgrowth cells from diabetic animals is attenuated by SIRT1 activation. Stem Cells Transl Med 2012;1(12):921-6
   Google Scholar
• Westerweel PE, Teraa M, Rafii S, et al. Impaired endothelial progenitor cell mobilization and dysfunctional bone marrow stroma in diabetes mellitus. PLoS One 2013;8(3):e60357
   Google Scholar
• Jung C, Rafnsson A, Shemyakin A, et al. Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes. Int J Cardiol 2010;143(3):368-72
   Google Scholar
• Hazra S, Jarajapu YP, Stepps V, et al. Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model. Diabetologia 2013;56(3):644-53
   PubMed Web of Science ®Google Scholar
• Aicher A, Heeschen C, Mildner-Rihm C, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003;9(11):1370-6
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5(4):434-8
   PubMed Web of Science ®Google Scholar
• Thum T, Fraccarollo D, Schultheiss M, et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 2007;56(3):666-74
   Google Scholar
• Chen YH, Lin SJ, Lin FY, et al. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 2007;56(6):1559-68
   Google Scholar
• Krankel N, Adams V, Linke A, et al. Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler Thromb Vasc Biol 2005;25(4):698-703
   Google Scholar
• Kuliszewski MA, Ward MR, Kowalewski JW, et al. A direct comparison of endothelial progenitor cell dysfunction in rat metabolic syndrome and diabetes. Atherosclerosis 2013;226(1):58-66
   Google Scholar
• Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002;106(22):2781-6
   PubMed Web of Science ®Google Scholar
• Ii M, Takenaka H, Asai J, et al. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ Res 2006;98(5):697-704
   PubMed Web of Science ®Google Scholar
• Segal MS, Shah R, Afzal A, et al. Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes 2006;55(1):102-9
   Google Scholar
• Seeger FH, Haendeler J, Walter DH, et al. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 2005;111(9):1184-91
   Google Scholar
• Yan J, Tie G, Wang S, et al. Type 2 diabetes restricts multipotency of mesenchymal stem cells and impairs their capacity to augment postischemic neovascularization in db/db mice. J Am Heart Assoc 2012;1(6):e002238
   Google Scholar
• Jin P, Zhang X, Wu Y, et al. Streptozotocin-induced diabetic rat-derived bone marrow mesenchymal stem cells have impaired abilities in proliferation, paracrine, antiapoptosis, and myogenic differentiation. Transplant Proc 2010;42(7):2745-52
   Google Scholar
• Januszyk M, Sorkin M, Glotzbach JP, et al. Diabetes irreversibly depletes bone marrow-derived mesenchymal progenitor cell subpopulations. Diabetes 2014. [Epub ahead of print]
   Google Scholar
• El-Ftesi S, Chang EI, Longaker MT, Gurtner GC. Aging and diabetes impair the neovascular potential of adipose-derived stromal cells. Plast Reconstr Surg 2009;123(2):475-85
   Google Scholar
• Cianfarani F, Toietta G, Di Rocco G, et al. Diabetes impairs adipose tissue-derived stem cell function and efficiency in promoting wound healing. Wound Repair Regen 2013;21(4):545-53
   PubMed Web of Science ®Google Scholar
• Fadini GP, Boscaro E, Albiero M, et al. The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. Diabetes Care 2010;33(7):1607-9
   PubMed Web of Science ®Google Scholar
• Kahn J, Byk T, Jansson-Sjostrand L, et al. Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood 2004;103(8):2942-9
   Google Scholar
• Wang CH, Ting MK, Verma S, et al. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus. Am Heart J 2006;152(6):1051 e1051-8
   Google Scholar
• Sorrentino SA, Bahlmann FH, Besler C, et al. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 2007;116(2):163-73
   PubMedGoogle Scholar
• Verma S, Kuliszewski MA, Li SH, et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004;109(17):2058-67
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Aicher A, Vasa M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001;108(3):391-7
   PubMed Web of Science ®Google Scholar
• Marchetti V, Menghini R, Rizza S, et al. Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling. Diabetes 2006;55(8):2231-7
   Google Scholar
• Prevention CFDCA. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States. U.S. Department of Health and Human Services; Atlanta, GA, USA: 2011
   Google Scholar
• Abaci A, Oguzhan A, Kahraman S, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999;99(17):2239-42
   Google Scholar
• Ding G, Qin Q, He N, et al. Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma. J Mol Cell Cardiol 2007;43(1):73-84
   PubMed Web of Science ®Google Scholar
• Frystyk J, Tarnow L, Hansen TK, et al. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005;48(9):1911-18
   PubMed Web of Science ®Google Scholar
• Mahadev K, Wu X, Donnelly S, et al. Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovasc Res 2008;78(2):376-84
   Google Scholar
• Shibata R, Sato K, Pimentel DR, et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 2005;11(10):1096-103
   PubMed Web of Science ®Google Scholar
• Tao L, Gao E, Jiao X, et al. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 2007;115(11):1408-16
   PubMed Web of Science ®Google Scholar
• Obata Y, Yamada Y, Kyo M, et al. Serum adiponectin levels predict the risk of coronary heart disease in Japanese patients with type 2 diabetes. J Diabetes Investig 2013;4(5):475-82
   Google Scholar
• Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002;13(1):134-41
   PubMed Web of Science ®Google Scholar
• Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 1996;98(4):894-8
   Google Scholar
• Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007;59(4):418-58
   PubMed Web of Science ®Google Scholar
• Boodhwani M, Sodha NR, Mieno S, et al. Insulin treatment enhances the myocardial angiogenic response in diabetes. J Thorac Cardiovasc Surg 2007;134(6):1453-60. discussion 1460
   Google Scholar
• Lee SW, Won JY, Lee HY, et al. Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-beta1/ERK/caspase-9 phosphorylation cascade. Mol Med 2011;17(9-10):1095-106
   PubMed Web of Science ®Google Scholar
• Tuo QH, Zeng H, Stinnett A, et al. Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis. Am J Physiol Heart Circ Physiol 2008;294(6):H2547-57
   Google Scholar
• Fagiani E, Christofori G. Angiopoietins in angiogenesis. Cancer Lett 2013;328(1):18-26
   PubMed Web of Science ®Google Scholar
• Chen JX, Stinnett A. Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice. Arterioscler Thromb Vasc Biol 2008;28(9):1606-13
   Google Scholar
• Chen JX, Tuo Q, Liao DF, Zeng H. Inhibition of protein tyrosine phosphatase improves angiogenesis via enhancing Ang-1/Tie-2 signaling in diabetes. Exp Diabetes Res 2012;2012:836759
   PubMedGoogle Scholar
• Hou Z, Nie C, Si Z, Ma Y. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1alpha. Diabetes Res Clin Pract 2013. [Epub ahead of print]
   Google Scholar
• Grutzmacher C, Park S, Zhao Y, et al. Aberrant production of extracellular matrix proteins and dysfunction in kidney endothelial cells with a short duration of diabetes. Am J Physiol Renal Physiol 2013;304(1):F19-30
   Google Scholar
• Celec P, Hodosy J, Gardlik R, et al. The effects of anti-inflammatory and anti-angiogenic DNA vaccination on diabetic nephropathy in rats. Hum Gene Ther 2012;23(2):158-66
   Google Scholar
• Olson FJ, Stromberg S, Hjelmgren O, et al. Increased vascularization of shoulder regions of carotid atherosclerotic plaques from patients with diabetes. J Vasc Surg 2011;54(5):1324-31. e1325
   Google Scholar
• Zhang SX, Wang JJ, Lu K, et al. Therapeutic potential of angiostatin in diabetic nephropathy. J Am Soc Nephrol 2006;17(2):475-86
   Google Scholar